PetMed Express, Inc. (NASDAQ:PETS) declared a quarterly dividend on Monday, January 22nd, RTT News reports. Shareholders of record on Monday, February 5th will be paid a dividend of 0.25 per share on Friday, February 16th. This represents a $1.00 annualized dividend and a yield of 1.88%. This is an increase from PetMed Express’s previous quarterly dividend of $0.20.
PetMed Express (NASDAQ:PETS) opened at $53.24 on Monday. The stock has a market cap of $1,096.97, a PE ratio of 35.73, a price-to-earnings-growth ratio of 3.24 and a beta of 1.12. PetMed Express has a twelve month low of $19.21 and a twelve month high of $53.90.
PetMed Express (NASDAQ:PETS) last issued its earnings results on Monday, January 22nd. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.13. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The business had revenue of $60.10 million during the quarter, compared to analysts’ expectations of $56.76 million. During the same period in the previous year, the company earned $0.24 earnings per share. The business’s revenue for the quarter was up 13.6% compared to the same quarter last year. analysts predict that PetMed Express will post 1.64 EPS for the current fiscal year.
Several research firms have recently weighed in on PETS. Credit Suisse Group reissued an “underperform” rating and set a $19.00 price objective on shares of PetMed Express in a report on Monday, October 2nd. ValuEngine cut shares of PetMed Express from a “buy” rating to a “hold” rating in a report on Monday, October 2nd. Zacks Investment Research cut shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a report on Monday, September 25th. BidaskClub cut shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a report on Friday. Finally, Northcoast Research set a $58.00 price objective on shares of PetMed Express and gave the company a “buy” rating in a report on Wednesday, January 3rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have given a buy rating to the company. PetMed Express has an average rating of “Hold” and a consensus price target of $42.80.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.